Position in BCAB
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$43,701
-$40,880 QoQ
Shares Held
10,556
-98.0% QoQ
Ownership
0.634%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 21 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,189,780,209 across 296 Biotechnology names. BCAB ranks #285 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in BCAB
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,701 | 10,556 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $84,581 | 525,352 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $298,400 | 525,353 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $361,442 | 525,353 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $208,039 | 525,353 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $182,297 | 525,353 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $310,483 | 525,353 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $924,621 | 525,353 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $1,637,633 | 1,195,353 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $4,280,209 | 1,244,247 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $2,767,997 | 1,125,203 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $474,507 | 279,122 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $2,077,170 | 692,390 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,855,605 | 692,390 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,288,606 | 398,619 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,299,366 | 298,619 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $423,564 | 148,619 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $907,785 | 181,557 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,582,120 | 182,482 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $5,435,829 | 184,641 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $15,791,253 | 372,611 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $390,806 | 7,687 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||